Raymond James Financial
ARDT

Raymond James Financial’s Ardent Health ARDT Stock Holding History

Raymond James Financial’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-146
Closed -$1.99K – 6908
2025
Q2 		$1.99K Buy
+146
New +$1.97K ﹤0.01% 6415

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.18B AUM 19.62% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $80M AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Raymond James Financial's ARDT Position: Q3 2025 in Review

Raymond James Financial sold out of Ardent Health (ARDT) in Q3 2025, closing a stake of 146 shares — an estimated $1.99K sold.

Raymond James Financial first reported a position in ARDT in Q2 2025 and held it in 1 quarter. The position peaked at $1.99K in Q2 2025. 123 funds tracked by Wall St. Rank hold ARDT as of Q3 2025.

  • Raymond James Financial reported no remaining Ardent Health position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 146 Ardent Health shares in Q3 2025, an estimated $1.99K.
  • Raymond James Financial first reported a position in Ardent Health in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Ardent Health position peaked at $1.99K in Q2 2025.
  • 123 funds tracked by Wall St. Rank held Ardent Health as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.